Related Experiment Video
Updated: Feb 13, 2026
08:03
Multi-analyte Biochip MAB Based on All-solid-state Ion-selective Electrodes ASSISE for Physiological Research
Published on: April 18, 2013
17.8K
Tanezumab: a selective humanized mAb for chronic lower back pain
Michael P Webb1, Erik M Helander2, Bethany L Menard2
1Department of Anesthesiology, North Shore Hospital, Auckland, New Zealand.
Therapeutics and Clinical Risk Management
|March 6, 2018
Summary
Tanezumab effectively reduced chronic lower back pain but showed adverse effects, necessitating further safety studies for this novel nerve growth factor inhibitor.
Area of Science:
- Pain Management
- Pharmacology
- Immunology
Background:
- Chronic lower back pain affects 20% globally and is a leading cause of disability.
- The opioid epidemic necessitates novel, safer pain therapeutics.
- Nerve growth factor (NGF) plays a key role in pain signaling and is implicated in chronic pain conditions.
Purpose of the Study:
- To examine the efficacy and safety of tanezumab for chronic lower back pain.
- To evaluate tanezumab as a potential alternative to opioid analgesics.
Main Methods:
- Review of randomized controlled trials on tanezumab for chronic lower back pain.
- Analysis of tanezumab's mechanism of action as a monoclonal antibody inhibiting NGF.
Main Results:
- Tanezumab demonstrated effectiveness as a pain modulator in clinical trials.
- Adverse effects were observed, leading to a US FDA clinical hold for certain doses.
Conclusions:
- Tanezumab shows promise as an analgesic for chronic lower back pain.
- Further investigation is required to fully understand its safety profile and optimize therapeutic use.
Related Concept Videos
01:24Biodiversity and Human Values
17.2K
Human civilization relies on biodiversity in many ways. Sudden changes in species biodiversity result in environmental changes that can modify weather patterns and therefore human civilizations.
17.2K
01:20Pain
1.4K
Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
1.4K
01:32What is Natural Selection?
129.8K
Natural selection is an evolutionary process in which individuals with survival-promoting traits reproduce at higher rates. These favorable traits become more common within a population or species. Naturally selected traits initially arise via random genetic mutations. In order for selection to occur, there must be variation within a population, the trait controlling the variation must be heritable, and there must be an evolutionary advantage for variation in the trait.
129.8K
00:57Antibiotic Selection
60.2K
Overview
60.2K
01:46Types of Selection
45.3K
Natural selection influences the frequencies of particular alleles and phenotypes within populations in several different ways. Primarily, natural selection can be directional, stabilizing, or disruptive. Directional selection favors one extreme trait and shifts the population towards that phenotype while selecting against individuals displaying alternate traits. Stabilizing selection favors an intermediate trait with a narrow range of variation. Deviation from the optimal phenotype towards an...
45.3K
01:25Analgesia and Pain Management
1.9K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.9K